You are here: Home
Health and Fitness
Medical
Successful treatment of Muscular dystrophy patients
Successful treatment of Muscular dystrophy patients
May 12, 2011 Medical news in NOIDA,U.P, India, Republic of
Dr. Ramesh Bhardwaj, a senior homeopathic consultant, president of homeopathic medical association has proved that there is a way to lead a healthy and normal productive life for muscular dystrophy. Good diet and homeopathic remedy found to be very effect
FOR IMMEDIATE RELEASE
NOIDA,
U.P,
India, Republic of
(Free-Press-Release.com) May 12, 2011 --
Muscular dystrophy refers to a group of genetic, hereditary muscle diseases that cause progressive muscle weakness. Muscular dystrophy are characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue. Nine diseases including Duchenne, Becker, limb girdle, congenital, facio scapulohumeral, myotonic, oculopharyngeal, distal, and Emery-Dreifuss are always classified as muscular dystrophy.
Types of Muscular dystrophy
Becker's muscular dystrophy
Becker muscular dystrophy (BMD) is a less severe variant of Duchenne muscular dystrophy and is caused by the production of a truncated, but partially functional form of dystrophin.
Survival is usually into middle age.
Congenital muscular dystrophy
Age at onset: birth; symptoms include general muscle weakness and possible joint deformities; disease progresses slowly; shortened life span.
Congenital muscular dystrophy includes several disorders with a range of symptoms. Muscle degeneration may be mild or severe. Problems may be restricted to skeletal muscle, or muscle degeneration may be pair with effects on the brain and other organ systems. A number of the forms of the congenital muscular dystrophies are caused by defects in proteins that are thought to have some relationship to the dystrophin-glycoprotein complex and to the connections between muscle cells and their surrounding cellular structure. Some forms of congenital muscular dystrophy show severe brain malformations, such as lissencephaly and hydrocephalus.
Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is the most common childhood form of muscular dystrophy. DMD usually becomes clinically evident when a child begins walking. Patients typically require a wheelchair by age 10 to 12 and die in their late teens or early 20s. In the early 1990s, researchers identified the gene for the protein dystrophin which, when absent, causes DMD. The dystrophin gene is the largest known gene in humans. Since the gene is on the X-chromosome, this disorder affects primarily males. Females who are carriers have milder symptoms. Sporadic mutations in this gene occur frequently, accounting for a third of cases. The remaining two-thirds of cases are inherited in a recessive pattern. age at onset: two to six years; symptoms include general muscle weakness and wasting; affects pelvis, upper arms, and upper legs; eventually involves all voluntary muscles; survival beyond 20 years is rare.
Dystrophin is part of a complex structure involving several other protein components. The "dystrophin-glycoprotein complex" helps anchor the structural skeleton within the muscle cells, through the outer membrane of each cell, to the tissue framework that surrounds each cell. Due to defects in this assembly, contraction of the muscle leads to disruption of the outer membrane of the muscle cells and eventual weakening and wasting of the muscle.
Distal muscular dystrophy
Distal muscular dystrophies' age at onset: 40 to 60 years; symptoms include weakness and wasting of muscles of the hands, forearms, and lower legs; progress is slow and not life-threatening.
Miyoshi myopathy, one of the distal muscular dystrophies, causes initial weakness in the calf muscles, and is caused by defects in the same gene responsible for one form of Limb Girdle Muscular Dystrophy.
Emery-Dreifuss muscular dystrophy
Age at onset, childhood to early teens. Symptoms include weakness and wasting of shoulder, upper arm, and shin muscles; joint deformities are common; progress is slow; sudden death may occur from cardiac problems.
Facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) initially affects muscles of the face, shoulders, and upper arms with progressive weakness. Symptoms usually develop in the teenage years. Some affected individuals become severely disabled. The pattern of inheritance is autosomal dominant, but the underlying genetic defect is poorly understood. Most cases are associated with a deletion near the end of chromosome 4.
Limb-girdle muscular dystrophy
Limb-girdle muscular dystrophy's is also called LGMD. LGMD's all show a similar distribution of muscle weakness, affecting both upper arms and legs. Many forms of LGMD have been identified, showing different patterns of inheritance (autosomal recessive vs. autosomal dominant). In an autosomal recessive pattern of inheritance, an individual receives two copies of the defective gene, one from each parent. The recessive LGMDs are more frequent than the dominant forms, and usually have childhood or teenage onset. The dominant LGMDs usually show adult onset. Some of the recessive forms have been associated with defects in proteins that make up the dystrophin-glycoprotein complex.
Death from LGMD is usually due to cardiopulmonary complications.
Myotonic muscular dystrophy
Myotonic MD's age at onset: 20 to 40 years
Myotonic muscular dystrophy is the most common adult form of muscular dystrophy. It is marked by myotonia as well as muscle wasting and weakness. Myotonic dystrophy varies in severity and manifestations and affects many body systems in addition to skeletal muscles, including the heart, endocrine organs, eyes, and gastrointestinal tract. Myotonic dystrophy follows an autosomal dominant pattern of inheritance. Myotonic dystrophy results from the expansion of a short repeat in the DNA sequence. In other words, the gene defect is an abnormally long repetition of a three- or four-letter "word" in the genome. While the exact mechanism of action is not known, this molecular change may interfere with the production of important muscle proteins.
Oculopharyngeal muscular dystrophy
Oculopharyngeal MD's age at onset: 40 to 70 years; symptoms affect muscles of eyelids, face, and throat followed by pelvic and shoulder muscle weakness, has been attributed to a short repeat expansion in the genome which regulates the translation of some genes into functional proteins.
Principal symptoms include:
* Progressive Muscular weakness
* Poor Balance
* Frequent Falls
* Walking Difficulty
* Waddling Gait
* Calf Pain
* Limited Range of Movement
* Muscle Contractual
* Respiratory Difficulty
* Drooping Eyelids
* Scoliosis (curvature of the spine)
* Inability to walk
Some types of Muscular Dystrophy can affect the heart, causing cardiomyopathy or arrhythmias.
The prognosis for people with muscular dystrophy varies according to the type and progression of the disorder. Some cases may be mild and progress very slowly over a normal lifespan, while others produce severe muscle weakness, functional disability, and loss of the ability to walk.
There is no known cure for muscular dystrophy. Inactivity (such as bed-rest and even sitting for long periods) can worsen the disease. Physical therapy, Occupational therapy, speech therapy and orthopedic instruments (e.g., wheelchairs, standing frames) may be helpful.
IS THERE A WAY OUT?
To a family with a child with muscular dystrophy, it must seem like the worst disease. To what extent might the remedy enable the sufferer to overcome the existing condition? There is considerable good news.
Dr. Ramesh Bhardwaj, a senior homeopathic consultant, president of homeopathic medical association has proved that there is a way to lead a healthy and normal productive life for muscular dystrophy. Good diet and homeopathic remedy found to be very effective and successful in muscular dystrophy patients.
It is found that, with the start of medicine there is gradual improvement in the patient’s condition with marked improvement in muscle strength, improved sleeping and eating patterns and weight gain within 1-2 months. Early initiation of treatment in the course of this disease can help a lot in reducing future disability and prolonging survival.
we have more than 3000 patients of all types of muscular dystrophy from india and all over the world. we have notice up to 80% improvement in our patients.
dr. bhardwaj has been awarded with "THE BEST HOMOEOPATH OF THE YEAR" since last 3 years
" THE MOST SUCCESSFUL PHYSICIAN IN TREATING MUSCULAR DYSTROPHY 2010"
Contact : Dr. Ramesh Bhardwaj
"Homoeopathic World", Noida
Mobile : 09811127065
email id:-dr.rameshbhardwaj@yahoo.com
website - http://www.homoeopathic-world.com
Becker Muscular dystrophy Congenital muscular dystrophy Duchenne Muscular Dystrophy facio scapulohumeral Muscular Limb girdle muscular dystrophy muscular dystrophy myotonic muscular dystrophy oculopharyngea Muscular dystro
People who viewed this press release also interested in the following topics: duchenne muscular dystrophy and skeletal muscle tissue, and duchenne muscular dystrophy nagpur.
Where: Shanghai,China (Mainland)
Industry: Health & Beauty
Where: Poznan,Poland
Industry: Health & Beauty
Where: Tel Aviv,Israel
Industry: Health & Beauty
Post your news to the World.See you news here immediately. It's easy and free!
Create free account or Login.


